177Lu-OPS201

Lu-177 OPS201 · Ipsen

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for 177Lu-OPS201, covering 2020-10-30 to 2023-07-19. Get the full timeline:

Most recent: Clinical Trial Update: Study to Evaluate the Safety and Preliminary Efficacy of 177Lu-OPS201 in NETs [Phase 1, Phase 2]